Physician profile
Feng Li
NPI 1003182593
$53,452.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $827 · 2021: $368 · 2022: $112 · 2024: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $40,000.00 | 2019 | |
| Boston Scientific Corporation | $11,739.83 | 2019-2022 | |
| Apollo Endosurgery US INC | $278.57 | 2021 | |
| Ironwood Pharmaceuticals, INC | $258.65 | 2019-2020 | |
| Abbvie INC. | $217.01 | 2019-2020 | |
| Endogastric Solutions, INC | $203.43 | 2020-2024 | Esophyx |
| Allergan, INC. | $154.76 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.25 | 2019-2020 | |
| Gilead Sciences, INC. | $102.13 | 2019-2020 | |
| Amarin Pharma, INC. | $92.22 | 2020 | |
| Redhill Biopharma INC. | $77.76 | 2020 | |
| Erbe USA INC | $74.21 | 2019 | |
| Olympus America INC. | $66.41 | 2019-2020 | |
| Amgen INC. | $26.00 | 2020 | |
| Braintree Laboratories, INC. | $23.95 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $18.33 | 2020 | |
| Merck Sharp & Dohme LLC | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Feng Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.